Province invests in the Ontario Institute for Regenerative Medicine

:  $25M over 5 years


April 23, 2015


Today’s Ontario Provincial Budget announced a commitment of $25M over 5 years to the Ontario Institute for Regenerative Medicine (OIRM). The vision of the OIRM is to revolutionize the treatment of degenerative diseases, making Ontario a global leader in the development and commercialization of stem cell-based products and therapies.
Janet Rossant, Interim Director of the OIRM, is thrilled with the news, “Ontario is at the forefront of innovation in regenerative medicine and we welcome the ongoing support of the Ontario government. This investment of $25M will ensure that we can continue to advance research and treatments for the benefit of our long term health and prosperity.”
“Ontario researchers discovered the use of stem cell therapies, which can now transform the way we treat degenerative diseases, while presenting a significant economic potential for our province. This $25M investment will enable the Ontario Institute for Regenerative Medicine to continue their work developing new treatments that will bring tangible benefits to Ontarians and have significant marketplace potential.” – The Honourable Reza Moridi, Minister of Research and Innovation